Michael Zdanowski

Insider Reports History

Location
Wellesley, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Zdanowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Chief Technology Officer Stock Appreciation Right 150,000 01 Feb 2023 Direct
Talaris Therapeutics, Inc. Chief Technology Officer Stock Option (Right to Buy) 150,000 01 Feb 2023 Direct

Insider Reports Filed by Michael Zdanowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRML Talaris Therapeutics, Inc. 01 Feb 2023 2 $0 4 Chief Technology Officer 03 Feb 2023, 16:02
TRML Talaris Therapeutics, Inc. 10 Sep 2022 1 $0 4 Chief Technology Officer 13 Sep 2022, 16:31
TRML Talaris Therapeutics, Inc. 01 Feb 2022 2 +$19,110 4 Chief Technology Officer 02 Feb 2022, 17:00